Primary Job Title Co-Founder & CEO Primary Organization 
ObsEva
Location Geneva, Geneve, Switzerland Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Ernest Loumaye brings to ObsEva an extensive experience in pharma product development and management of biopharmaceutical companies.
After a brief academic career at Louvain University Hospital, he joined Serono as Head of Clinical Development for Reproductive Health (Geneva and Boston). He contributed actively to the worldwide registration of
three important biotechnology products. In 2003, Ernest Loumaye joined Ipsen in Paris as Vice President, Medical Sciences. In 2006, Ernest Loumaye co-founded PregLem, a Swiss based specialty biopharmaceutical company. As CEO, he led the company up to the successful European registration of Esmya®, its lead product. The company was acquired by Gedeon Richter Plc. in 2010.
In 2012, Ernest co-founded ObsEva and since then is the CEO of ObsEva. Currently, he is also Chairman of the Board of Directors of GenKyoTex.
Ernest Loumaye was a visiting Professor of Reproductive Endocrinology at Louvain University, Brussels from 2002 to 2010, where he held a fulltime clinical and academic position until 1991.
He holds MD, Ph.D degrees and a specialization in Obstetrics and Gynaecology from Louvain University, Belgium. He was a research fellow at the National Institute of Child Health and Human Development in the US and is the author of over 90 publications in peer-reviewed journals.
